Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.







Date: 2018-01-26

 1600 UTC

Zoom Meeting Details

SNOMED Int'l Editorial Advisory group  

SNOMED International - Editorial advisory group conference call  
 UTC  

Please join my meeting from your computer, tablet or smartphone

https://snomed.zoom.us/j/807454545


Observers:

Apologies


 

Meeting Files


Meeting recording

The folder containing the meeting recordings is located here.

 

Objectives

  • Obtain consensus on agenda items

Discussion items

ItemDescriptionOwnerNotesDiscussionAction
1Call to order and role callJCA



 

2

Conflicts of interest

Approval of minutes from Bratislava

JCA

  •  Minutes approved
3ECE UpdateBGO
  • Reactive arthritis and modeling extraarticular manifestations using simple co-occurrence
  • Test of allergic disorder model as pathologic structure
  • Sepsis
    • Sepsis
      1. Agreement to add dysregulated host response as a pathological process.
      2. Agreement not to add pathological process infectious process which would result in sepsis being defined as organ dysfunction syndrome co-occurrent and due to infectious disease.

  • Test of device complications model
    • Device complications
      Problems with the device itself should be a finding and not a disorder. This would allow some rearrangement of the current device problem findings. The modleing structure would be to use the INTERPRETS/HAS INTERPRETATION pair to define the findings.
      Should also create a more specific "device failure" to segregate from general external equipment failure.
      desire to see more examples for each of the three patterns.


  •  Bruce Goldberg to test modeling of sepsis both with and without the PATHOLOGICAL PROCESS
  •  Bruce Goldberg to test the three patterns related to devices. Tracker item to be developed.
4Drug Model UpdateTMO


5Observables Model UpdateDKA


6

Revision of editorial guidance for PATHOLOGICAL PROCES concerning "Inflammation (qualifier value)JCA

Current editorial guidance on the use of the Pathological Process Value = 257552002 Inflammation (qualifier value)

The current editorial guidance on the use of this process value eventually resulted in the need to distinguish between process and structure in the Morphologic abnormality hierarchy. E.g. 23583003 |Inflammation (morphologic abnormality)| vs. 409774005 |Inflammatory morphology (morphologic abnormality)|.

There is a tracker item: IHTSDO-558

Initial draft Fast track document : https://docs.google.com/document/d/1r1x9hoW4S4s5gO0Ce9pHth6ofkI6UJhfzfEUtS1l-8U/edit

Questions:

  • Should the use of PATHOLOGICAL PROCESS be expanded to coincide with the increased need to support the SPD model?
  • Should a project to decompose the conflated morphology concepts (i.e. process and structure, structure and anatomy, structure and disposition)?
  • Due to the significant impact this will have on modeling patterns and possible to inferences, should this be approved by members prior to construction?

This notion is critical to the continued improvement of content in SNOMED CT; however, it adds substantial complexity and will require clear and possibly extensive guidance to ensure consistent application. Templates may be the most efficient way to guarantee compliance.



7Disorder without disorderJCA

Common pattern in classifications such as ICD. Currently all are primitive in SNOMED CT.

One potential modeling pattern proposed is the use of the Situation model with one "known present" relationship group and one "known absent" relationship group.

The problem with specific negation is that it is silent about other clinical aspects that may be of significance.

What is the purpose of calling out one specific clinical manifestation?

Comments solicited from, CMAG.



8Lexical inconsistenciesJCA

We received a comment from a dutch lexographer:

Dear fellow terminologist(s),

I am the Dutch medical linguist currently in charge of checking translations of SNOMED terms into Dutch (as for the Netherlands, not for Belgium) on morphosyntactical rules. In 2015 I translated the IHTSDO translation guidelines into Dutch as an assignment by Nictiz, the Dutch release centre.

It occurs to me that in compound adjectives in many SNOMED terms, the dash has been left out:
pacing induced cardiomyopathy = ‘a sentence in past tense stating that …’?
§ where I expect: pacing-induced cardiomyopathy = cardiomyopathy induced by pacing
left sided atrium connecting to both ventricles > ‘lefties sitting next to…’?
§ where I expect: left-sided atrium

This will unintentionally render a collocation into a sentence, as in many cases the past participle is a homograph of the verb in past tense. In most cases however, the term will be interpreted correctly anyhow.

Why does SNOMED not follow commonly taught spelling rules in English? I do know that in informal American English this compounding dash has become somewhat uncommon. Likewise, the adverbial suffix ‑ly was abolished in the USA already a while ago. Possibly this dash will join its fate. Must SNOMED anticipate this? I feel that a mere spelling inaccuracy should not be a reason for terminologists to embrace it.

Likewise, the ISO 704 norm for terminology instructs that a term should not be capitalized without a reason. In Dutch we will spell stomach and not Stomach. As a lexicographer I come across this irrational, somewhat ‘American’ typesetting custom in a very few, mostly obsolete medical glossaries only. Has SNOMED International never considered running some semi-conditional routine for replacing an initial letter in upper case where not required with the letter in lower case?

Has SNOMED International been spending any thoughts on these two orthographical matters? I hope that you will be willing to share your thoughts on this with me. It will be interesting to be able to learn from each other’s expertise and practice!



79Specimen from subjects other than the patient JCA

Currently we have many concepts in the specimen hierarchy that include “from patient”as well as those that do not include it as an ancestor.  Since the subject of record is the default for specimens, we would like to retire these apparent duplicates, but then we run into the problem of specimens derived from other sources such as donors or normal control patients. 

They cannot be subtypes if the intended meaning is “subject of record”..or can they, since the context is implied?  How do we structure the specimen hierarchy to account for this? 

What are the analytical implications of having different sources for specimens as subtypes of one another?

No testing of options for this item has been performed since the last meeting. Issues still remaining:

  • Eliminating the soft default (yes or no)
  • Creating unspecified SPECIMEN SOURCE concepts only where both patient-oriented and non-patient specimens are required.
  • Resolving issues with specimen sources that are both patient and non-patient oriented (i.e. autologous blood products)
  • Resolution of non-patient subtypes under unspecified SPECIMEN SOURCE (i.e soft default) concepts
  •   Jim Case to develop option to consider for solution of this specimen unspecificity issue
  •  Jim Case to present to CMAG for their input on the perceived impact of proposed options
810What is an "infected prosthesis"JCAUpdate: Proposed model (Infected Prosthesis) was tested and reviewed by the ECE. Construction has been performed and editorial guidance will be updated as necessary
  •  Jim Case to verify editorial guidance added.

11“Acquired” disorders testingJCA
  • There are existing "Acquired X (morphologic abnormality)" concepts, but these are very much analogous to the "Congenital X" morphologies that we are trying hard to get rid of. 
  • "Acquired" and "Congenital" are not morphologies, but timeframes.  We do not have a way of denoting "All periods of life after birth" like we do for "Congenital".  If we did, then we could create a fully defined concept grouper of "Acquired disorder", which would subsume all concepts that had any OCCURRENCE value later than "At birth", but then it would require that all acquired disorders have a valid OCCURRENCE relationship.
  • This approach might also open the door that all disorders that are not specifically “Congenital” have an OCCURRENCE relationship stating that it is required, which seems to be “overmodeling”.  While we can use the "Acquired deformity" morphology concepts currently, due to the lack of many useful subtypes of "Acquired X" morphologies, it would only be a partial solution. 
  • One potential solution is to create a primitive grouper of "Acquired disorder" and then using that as the proximal primitive parent, adding the necessary relationships to make acquired disorders defined.  It is a kludge, but it would allow for full definition.

Update: A grouper "period of life" term encompassing all stages of life (Postnatal (qualifier value)) after birth was created. Over 100 concepts with the string "Acquired" were reviewed and fully defined using the OCCURRENCE attribute. There were no adverse impacts from this initial test.

One conditional issue relates to the ability to define terms with the string "juvenile". The definition of juvenile differs in age ranges from jurisdiction to jurisdiction. Likewise the definitions of age ranges for "childhood" and "adolescent". There is an inactive concept 282035009 - Juvenile (qualifier value) that was once a subtype of "Period of life", but was inactivated as duplicate to 59223006 - Juvenile (finding).

The process to progress this needs to be determined.

2017-11-03: A related tracker exists: PCP-71. The work related to this item will be linked to that tracker.




  •  Jim Case will create a tracker and test the aggregate period of life concept as a way to define acquired disorders.
  •  Develop editorial guidance for how to properly use the aggregate "period of life" term.
12Update of EAG WorkplanJCAReview and revision of current workplan

Continued to next call due to lack of time.

  •  Jim Case to update workplan based on input from the EAG members.
14ECE updateBGO
  • Reactive arthritis and modeling extraarticular manifestations using simple co-occurrence
  • Test of allergic disorder model as pathologic structure
  • Sepsis
    • Sepsis
      1. Agreement to add dysregulated host response as a pathological process.
      2. Agreement not to add pathological process infectious process which would result in sepsis being defined as organ dysfunction syndrome co-occurrent and due to infectious disease.

  • Test of device complications model
    • Device complications
      Problems with the device itself should be a finding and not a disorder. This would allow some rearrangement of the current device problem findings. The modleing structure would be to use the INTERPRETS/HAS INTERPRETATION pair to define the findings.
      Should also create a more specific "device failure" to segregate from general external equipment failure.
      desire to see more examples for each of the three patterns.

  •  Bruce Goldberg to test modeling of sepsis both with and without the PATHOLOGICAL PROCESS
  •  Bruce Goldberg to test the three patterns related to devices. Tracker item to be developed.
1513Future meetingsJCA